Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) — Net Asset Momentum
Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) recorded a net asset momentum of 11.9% as of December 2025, with net assets of CN¥3.00 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Sinopep-Allsino Biopharmaceutical Co. Lt to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Sinopep-Allsino Biopharmaceutical Co. Ltd. A Net Asset Momentum (2013–2025)
This chart tracks Sinopep-Allsino Biopharmaceutical Co. Ltd. A's year-over-year net asset growth across 13 annual reporting periods from 2013 to 2025. The most recent momentum reading is +11.9%, with net assets of CN¥3.00 Billion CNY as of December 2025. Read debt load of Sinopep-Allsino Biopharmaceutical Co. Lt for a breakdown of total debt and financial obligations.
Annual Net Asset History for Sinopep-Allsino Biopharmaceutical Co. Ltd. A (2013–2025)
The table below shows the complete annual net asset history for Sinopep-Allsino Biopharmaceutical Co. Ltd. A from 2013 to 2025, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Sinopep-Allsino Biopharmaceutical Co. Lt (688076) market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥3.00 Billion | CN¥6.74 Billion | CN¥3.74 Billion | ▲ +11.9% |
| 2024 | CN¥2.68 Billion | CN¥5.08 Billion | CN¥2.40 Billion | ▲ +22.5% |
| 2023 | CN¥2.19 Billion | CN¥3.55 Billion | CN¥1.36 Billion | ▲ +13.7% |
| 2022 | CN¥1.92 Billion | CN¥2.52 Billion | CN¥597.41 Million | ▲ +6.4% |
| 2021 | CN¥1.81 Billion | CN¥2.13 Billion | CN¥318.14 Million | ▲ +87.2% |
| 2020 | CN¥966.02 Million | CN¥1.40 Billion | CN¥429.55 Million | ▲ +15.1% |
| 2019 | CN¥838.98 Million | CN¥1.24 Billion | CN¥405.54 Million | ▲ +6.8% |
| 2018 | CN¥785.38 Million | CN¥1.05 Billion | CN¥265.47 Million | ▲ +144.5% |
| 2017 | CN¥321.20 Million | CN¥611.47 Million | CN¥290.27 Million | ▲ +818.9% |
| 2016 | CN¥34.95 Million | CN¥160.11 Million | CN¥125.16 Million | ▼ -52.3% |
| 2015 | CN¥73.32 Million | CN¥196.67 Million | CN¥123.35 Million | ▲ +441.5% |
| 2014 | CN¥-21.47 Million | CN¥151.58 Million | CN¥173.05 Million | ▼ -682.6% |
| 2013 | CN¥3.69 Million | CN¥166.81 Million | CN¥163.12 Million | — |